Why does my eyelid droop after Botox?
Because a little of the toxin has reached the levator palpebrae superioris, the muscle that lifts the upper lid. Botulinum toxin works by blocking the signal from a nerve to a muscle. When it stays in the frown or forehead muscle it was aimed at, the lines soften. When some of it travels, most likely through weak points in the thin membrane behind the brow bone, the orbital septum, the levator weakens and the lid sits lower. A heavy feeling in the lid or brow is the usual first sign.
A 2021 review gives a mean onset of 3 to 14 days after the injection, and a 2026 review puts it in the first week or up to 7 to 10 days. It is seen mostly after frown-line injections. In the pooled trial data below, it appeared only in the frown-line studies and not in the crow's feet studies. The eye itself is not diseased, and the lid recovers as the nerve supply to the levator recovers. The piece on botulinum toxin around the eye explains why this area is different, and the side effects of anti-wrinkle injections sets this droop beside the other effects.
Is it my eyelid or my brow?
Two different problems look alike in the mirror. In a true eyelid droop, the edge of the upper lid sits lower and can cover part of the pupil. In a heavy brow, the frontalis, the forehead muscle that holds the brow up, has been relaxed too low or too far out, the brow sinks, and a fold of skin hangs over the lid. The lid edge may be exactly where it was. Reviews of toxin in this area name both lid ptosis and brow ptosis as effects.
The difference matters for the drops in this article. They act on a small muscle inside the lid, so they cannot lift a brow. A brow that has dropped fades as the toxin does. A doctor separates the two by measuring the lid edge against the pupil, because the mirror and a worried eye are poor judges.
How common is a droopy eyelid after Botox?
Uncommon, and less so in experienced hands. In pooled data from nine registration studies of one toxin, with 1,678 participants, eyelid ptosis occurred in 1.8% of the people treated against none on placebo, and only in the frown-line studies. A meta-analysis of 16 randomised trials found a higher relative risk of ptosis with frown-line injection than with placebo (5.56, with a wide confidence interval of 1.68 to 18.38).
Reviews of the wider literature give about 2.5% overall, and a range of about 1 to 14% after frown-line injections, falling to under 1% in series from experienced injectors. The spread reflects technique, dose, the product and the face, and trial figures are a guide and not a prediction for any one person.
Which eye drops help a droopy eyelid after Botox?
The drop that reviews describe most often is apraclonidine 0.5% (sold as Iopidine), a glaucoma eye drop. It is an alpha-2 adrenergic agonist. The upper lid has a second, smaller lifting muscle, Muller's muscle, which sits just behind the levator and is driven by the sympathetic nervous system. The toxin has less access to it. The drop makes it contract, and the edge of the lid rises by about 1 to 2 mm. In a small cohort of 6 people with toxin ptosis, all six improved when re-examined 20 to 30 minutes after two drops.
This is an off-label use, because the drop is licensed for eye pressure and not for eyelids. The evidence is case reports, small series and expert practice, and the authors of a 2026 review say as much. Reviews describe the drops being used a few times a day until the droop settles. That is a description of practice and not a dosing instruction: a doctor who has examined the eye prescribes the drop and sets the schedule.
The other alpha-agonist drop is oxymetazoline 0.1% (sold as Upneeq). The US FDA approved it in July 2020 for acquired ptosis in adults, as one drop once daily. Its trials were in acquired ptosis in general and not specifically toxin droop. In a pooled analysis of two trials with 304 people, the lid edge rose 0.67 mm more than with the vehicle drop at day 14 (95% confidence interval 0.46 to 0.88), and reviews of toxin ptosis list it as an additional option. Which of these drops can be obtained in Malaysia varies, and the doctor will advise. Dr Catherine Chow, an oculoplastic surgeon, sets out what these eye drops can and cannot do, from the eye surgeon's side.
Who should not use these drops, and what are the cautions?
They are prescription medicines, and the labels carry cautions. The apraclonidine label lists allergy to apraclonidine or clonidine and treatment with monoamine oxidase (MAO) inhibitor medicines as reasons not to use it. Safety and effectiveness in children have not been established. It asks for caution in severe uncontrolled cardiovascular disease, including high blood pressure, and in coronary insufficiency, recent heart attack, cerebrovascular disease, chronic kidney failure and Raynaud's disease. Contact lenses come out before the drop.
The commonest problem is irritation and allergy: red, itchy, watery, uncomfortable eyes and swollen lids, after which the label says to stop. In a glaucoma trial of long-term use, 14.3% of treated patients stopped for side effects, mostly allergic-like reactions. A short course for a droopy lid is a different exposure, and the figure shows why repeated use is watched. A review adds that a larger pupil and angle-closure glaucoma are uncommon.
The oxymetazoline label asks for caution with cerebral or coronary insufficiency, Sjogren's syndrome and blood pressure problems, and with MAO inhibitors, and its safety is not established under 13. Its commonest reactions, in 1 to 5% of users, were surface damage to the front of the eye, redness, dry eye, blurred vision, stinging, irritation and headache. Tell the doctor about any heart condition, blood pressure problem, glaucoma, eye drops you already use and any medicine you take. An old bottle, or someone else's glaucoma drop, is not a substitute for an examination.
Are all glaucoma drops the same?
No. The drop used for a droopy lid is an alpha-agonist. A different family of glaucoma drop, the prostaglandin analogues, can do something close to the opposite over months to years. It is called prostaglandin-associated periorbitopathy: a deeper hollow in the upper lid, loss of fat around the eye and sometimes a droopy look. In 86 patients who had used one in a single eye for at least three months, 67.4% had at least one change around the eye, and the upper lid sulcus had deepened in 38.4%. In 9 patients, the changes partly improved a year after the drop was stopped.
Never stop a glaucoma drop without asking the eye doctor who prescribed it, because the pressure it controls protects the sight. Dr Catherine Chow, an oculoplastic surgeon, is writing on how these drops change the eyelids.
How long does a droopy eyelid after Botox last?
Usually weeks, and it is temporary. A 2026 review reports most cases resolving within 2 to 4 weeks, with some reports of a longer course. A 2021 review says typically 3 to 4 weeks, with full reversal reported up to 3 months, and a 2025 review says about 3 months, once the toxin's effect fades. The drops cover the gap. They do nothing to the toxin already in the muscle, and the lid falls back as each dose wears off.
Some droops last longer. In a series of 7 patients referred to an eye surgery service because the droop persisted, it lasted from 6 weeks to 13 months, and those are the harder cases that reach a specialist. The same authors suggested that a response to apraclonidine over a one-week trial might forecast the course, with responders likely to settle in 4 to 6 weeks and non-responders taking longer, and they graded that as low-level evidence. A droop that is not improving deserves a review, by the injecting doctor first and by an eye surgeon if it persists. Dr Catherine Chow explains why a droopy eyelid follows toxin injections and how long it takes to settle, with the eye surgeon's view of the same weeks.
What should I not do?
Do not have more toxin injected to correct it, as a first step. The toxin is the cause. A small-dose technique near the lid edge has been reported in a few cases from expert hands, and reviews say its details and evidence are thin, so it is not something to ask for. Do not massage, press or warm the lid hoping to move the toxin. Massage in the first hours is advised against because it may spread toxin, and no home measure is known to shorten the droop. A 2026 review found no supporting evidence for physical measures such as electrical stimulation or radiofrequency.
Do not borrow a glaucoma drop from a relative or use an old bottle. These drops have contraindications, and an unexamined droop may not be the toxin.
When is a droopy eyelid not from Botox?
A droop that begins around the time of an injection can have another cause, and a coincidence is easy to miss. See a doctor promptly for a droop with double vision, an eye that will not move fully in some direction, one pupil larger than the other, a new headache or eye pain, a lid that is fine in the morning and heavier by evening, or a lid that was already low before the treatment. A drooping face or mouth on one side, with weakness of an arm or slurred speech, is an emergency call. Pain or blurred vision is covered in when a treatment irritates the eye area.
A large pupil can rarely follow the toxin itself, as in a published case where it settled over three weeks. It still goes to an eye doctor, because a nerve problem looks the same. A droop that did not follow an injection, began weeks or months afterwards, or does not settle is an eye surgeon's question, and the cause is named before anything is prescribed.
Can it be prevented?
Mostly by technique, which belongs to the injector. The reviews list injecting about 1 cm above the brow when treating the frown, keeping the needle pointed away from the orbit, staying at least 1 cm from the orbital margin near the eye, and using a low volume placed superficially. They name technique as probably the most important factor, and a higher rate with inexperienced injectors. A history of a previous droop, myasthenia gravis, multiple sclerosis or Bell's palsy raises the risk, so tell the doctor beforehand.
On your side, the reviews advise against massaging the treated area or lying flat for 3 to 4 hours afterwards. Technique lowers the chance and cannot remove it. If a droop appears after anti-wrinkle injections anywhere, contact the doctor who treated you.
The honest complication
The evidence for these drops is thin. It rests on case reports, small series and expert practice, the use of apraclonidine for the eyelid is off-label, and the oxymetazoline trials were in acquired ptosis in general. A lift of 1 to 2 mm is useful for some lids and barely noticeable in others, it lasts hours, and the drops are not suitable for everyone. Whether a given drop is available in Malaysia varies. A droop is assessed first, and the drop, the wait and the review are decided from that examination.
